- Sponsored Content
- Upstream Processing
Not Your Typical CDMO: Comprehensive Cell Solutions
BPI Contributor
October 13, 2023
Sponsored Content
This interview features: Tracy Kinjerski, Vice President and General Manager, Comprehensive Cell Solutions, from Cell & Gene Manufacturing and Commercialization US 2023.
About the Author(s)
You May Also Like
Upcoming Webcasts
Insider News
Ingersoll Rand to bolster life sci presence with $2.3bn ILC Dover buy
May 2, 2024|2 Min ReadBioprocess industry eyes China's stimulus program amid funding woes
May 1, 2024|2 Min ReadBIOSECURE and Catalent deal could bag more biz for Thermo
April 29, 2024|3 Min ReadPfizer wins approval for $3.5m hemophilia B gene therapy
April 29, 2024|1 Min Read
Jun 17 - Jun 20, 2024
Jun 17 - Jun 20, 2024
Our Biopharmaceutical School is the perfect course to gain a well-rounded understanding of the Biopharmaceutical industry. Over three days, you will understand the principle steps in the biopharmaceutical lifecycle, including: raw material selection, up and downstream processes and core technology. Additionally, you will be familiarised with the latest industry trends, including Industry 4.0, and how these are likely to impact the industry’s evolution.
Through a combination of sessions led by experts from the likes of GSK and Pall Biotech, as well as group discussions with your peers, you will learn how to bring a biopharmaceutical drug to market. Each day will be chaired by a different member of the BioProcess International Academy faculty and there will also be time for networking and Q&As with the experts.
Learn More